Cedars-Sinai scientists have developed an experimental drug that repairs DNA and serves as a prototype for a new class of ...
NEET UG 2026 is expected on the first Sunday of May. Check your preparation with these high-yield Plant Physiology ...
12mon MSN
Small molecule discovery could open the door to new class of treatments for hard-to-treat cancers
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified a small molecule that can inhibit a cancer ...
This valuable study provides solid evidence for deficits in aversive taste learning and taste coding in a mouse model of autism spectrum disorders. Specifically, the authors found that Shank3 knockout ...
AstraZeneca advances its ambition to redefine hematology care with new data from its diverse pipeline and portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, ...
This important study shows that different forms and mixtures of cardenolide toxins in tropical milkweed, especially nitrogen- and sulfur-containing types, change how monarch caterpillars eat, grow, ...
Oral presentation from pooled analyses of the IMerge population suggests that treatment-emergent cytopenias may reflect on-target effects associated with meaningful clinical outcomes, including ...
New approaches hurdle biological barriers to attack recalcitrant targets to tackle difficult-to-treat and recurrent cancers.
UCB, a global biopharmaceutical company, today presented positive efficacy and safety results from the GEMZ phase 3 study investigating adjunctive fenfluramine (FFA) in children and adults with CDKL5 ...
Every school had a certified genius. They were the valedictorian, the kid who ruined the grading curve, the person whose future seemed like a straight, golden road paved with scholarships and success.
Everyday Health on MSN
What Are Peptide Injections?
TB-500, and copper peptide to build muscle, rejuvenate skin, and boost longevity. But do they work and are they safe?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results